Based on 15 years of research into the relationship between the autonomic nervous system, psychological state and circadian heart rhythm (CHR) architecture, Medibio’s patented technology has the potential to be the world’s first objective test for mental health.
Medibio’s Digital Mental Health Platform will transform the assessment and management of mental health by:
- Providing objective, quantifiable diagnosis
- Confirming the effectiveness of therapies
- Driving optimal disease management
Depression is estimated to cost US economy US$210 billion a year with the cost in Australia estimated at $12.6 billion annually.